Trypanosoma cruzi invades host cells through the activation of endothelin and bradykinin receptors: a converging pathway leading to chagasic vasculopathy
Contribuinte(s) |
UNIVERSIDADE DE SÃO PAULO |
---|---|
Data(s) |
21/10/2013
21/10/2013
2012
|
Resumo |
BACKGROUND AND PURPOSE Independent studies in experimental models of Trypanosoma cruzi appointed different roles for endothelin-1 (ET-1) and bradykinin (BK) in the immunopathogenesis of Chagas disease. Here, we addressed the hypothesis that pathogenic outcome is influenced by functional interplay between endothelin receptors (ETAR and ETBR) and bradykinin B2 receptors (B2R). EXPERIMENTAL APPROACH Intravital microscopy was used to determine whether ETR/B2R drives the accumulation of rhodamine-labelled leucocytes in the hamster cheek pouch (HCP). Inflammatory oedema was measured in the infected BALB/c paw of mice. Parasite invasion was assessed in CHO over-expressing ETRs, mouse cardiomyocytes, endothelium (human umbilical vein endothelial cells) or smooth muscle cells (HSMCs), in the presence/absence of antagonists of B2R (HOE-140), ETAR (BQ-123) and ETBR (BQ-788), specific IgG antibodies to each GPCRs; cholesterol or calcium-depleting drugs. RNA interference (ETAR or ETBR genes) in parasite infectivity was investigated in HSMCs. KEY RESULTS BQ-123, BQ-788 and HOE-140 reduced leucocyte accumulation in HCP topically exposed to trypomastigotes and blocked inflammatory oedema in infected mice. Acting synergistically, ETAR and ETBR antagonists reduced parasite invasion of HSMCs to the same extent as HOE-140. Exogenous ET-1 potentiated T. cruzi uptake by HSMCs via ETRs/B2R, whereas RNA interference of ETAR and ETBR genes conversely reduced parasite internalization. ETRs/B2R-driven infection in HSMCs was reduced in HSMC pretreated with methyl-beta-cyclodextrin, a cholesterol-depleting drug, or in thapsigargin-or verapamil-treated target cells. CONCLUSIONS AND IMPLICATIONS Our findings suggest that plasma leakage, a neutrophil-driven inflammatory response evoked by trypomastigotes via the kinin/endothelin pathways, may offer a window of opportunity for enhanced parasite invasion of cardiovascular cells. Instituto Nacional de Biologia Estrutural e Bio-Imagem do CNPq Instituto Nacional de Biologia Estrutural e BioImagem do CNPq PRONEX, FAPERJ [26/110.562/2010] PRONEX, FAPERJ CNPq CNPq National Institutes of Health (NIH) National Institutes of Health (NIH) [AI-076248] Fogarty International CenterNIH Fogarty International Center-NIH [D43-TW007129] |
Identificador |
BRITISH JOURNAL OF PHARMACOLOGY, MALDEN, v. 165, n. 5, supl. 1, Part 1, pp. 1333-1347, MAR, 2012 0007-1188 http://www.producao.usp.br/handle/BDPI/35324 10.1111/j.1476-5381.2011.01609.x |
Idioma(s) |
eng |
Publicador |
WILEY-BLACKWELL MALDEN |
Relação |
BRITISH JOURNAL OF PHARMACOLOGY |
Direitos |
restrictedAccess Copyright WILEY-BLACKWELL |
Palavras-Chave | #BRADYKININ #CARDIOMYOPATHY #CHAGAS DISEASE #CRUZIPAIN #ENDOTHELIN #OEDEMA #GPCRS #INVASION #KININOGENS #MICROCIRCULATION #TRYPANOSOMA CRUZI #SMOOTH-MUSCLE-CELLS #HEART-DISEASE #GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORS #UP-REGULATION #B-2 RECEPTOR #MAST-CELLS #INVASION #ETA #INFECTION #CAVEOLAE #PHARMACOLOGY & PHARMACY |
Tipo |
article original article publishedVersion |